Benitec Biopharma (BNTC) Other Non-Current Assets (2019 - 2026)
Benitec Biopharma (BNTC) reported Other Non-Current Assets of $200,000 for fiscal Q4 2026 (quarter ended Jun 30, 2026), up 263.6% from $55,000 a year earlier.
Powered by 
Analysis
Benitec Biopharma (BNTC) Other Non-Current Assets (2019 - 2026) Analysis & Trends
Dating back to fiscal Q4 2019, Benitec Biopharma's Other Non-Current Assets record includes 25 quarters.
- Other Non-Current Assets has a five-year compound annual growth rate of -27.3% (FY2021 to FY2026).
- By fiscal year, Other Non-Current Assets came in at $55,000 in FY2025 (-90.5%), $578,000 in FY2024 (-54.9%), $1.28 million in FY2023 (+46.2%) and $876,000 in FY2022 (-11.0%).
- Five-year quarterly Other Non-Current Assets spans a low of $55,000 in fiscal Q4 2025 and a high of $1.28 million in fiscal Q4 2023.
- Year over year, Other Non-Current Assets gained in three of the last seven quarters, with growth averaging 20.6%.
- The high point for year-over-year Other Non-Current Assets in five years was fiscal Q4 2026 (growth of 263.6%); the low point was fiscal Q4 2025 (a decline of 90.5%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 7.70 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 15.10 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 9.42 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 19.90 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | 700.00 Mn |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | - |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 14.60 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 4.90 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 10.02 Bn |
| 10 | Benitec Biopharma | 432.06 Mn | -216.04 Mn | - | 279,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 279,000.00 |
| Mar 31, 2026 | 79,000.00 |
| Dec 31, 2025 | 77,000.00 |
| Sep 30, 2025 | 595,000.00 |
| Jun 30, 2025 | 111,000.00 |
| Mar 31, 2025 | 521,000.00 |
| Dec 31, 2024 | 517,000.00 |
| Sep 30, 2024 | 619,000.00 |
| Jun 30, 2024 | 727,000.00 |
| Mar 31, 2024 | 389,000.00 |
| Dec 31, 2023 | 623,000.00 |
| Sep 30, 2023 | 762,000.00 |
| Jun 30, 2023 | 1.50 Mn |
| Mar 31, 2023 | 1.01 Mn |
| Dec 31, 2022 | 613,000.00 |
| Sep 30, 2022 | 794,000.00 |
| Jun 30, 2022 | 1.17 Mn |
| Mar 31, 2022 | 543,000.00 |
| Dec 31, 2021 | 685,000.00 |
| Sep 30, 2021 | 1.01 Mn |
API Access
Benitec Biopharma Other Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=BNTC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-current-assets", "ticker": "BNTC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=BNTC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();